chr6-51855874-A-G

Variant names:

• chr6-51855874-A-G
• rs201017366
• NM_138694.4:c.7911+19T>C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_Strong BP6 BS2

The NM_138694.4(PKHD1):​c.7911+19T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00034 in 1,583,284 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

• Frequency:
  • Genomes: 𝑓 0.00043 (0 hom., cov: 33)
  • Exomes 𝑓: 0.00033 (2 hom.)
• Consequence: PKHD1 NM_138694.4 intron
• Clinical Significance: Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1 B:2
• Conservation: PhyloP100: 2.29

Genes affected

PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]

ACMG classification

Our verdict: Benign. The variant received -9 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.8).
• BP6: Variant 6-51855874-A-G is Benign according to our data. Variant chr6-51855874-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 554778.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1, Benign=1}.
• BS2: High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
PKHD1	NM_138694.4	c.7911+19T>C		intron_variant	Intron 49 of 66	ENST00000371117.8	NP_619639.3

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
PKHD1	ENST00000371117.8	c.7911+19T>C		intron_variant	Intron 49 of 66	1	NM_138694.4	ENSP00000360158.3
PKHD1	ENST00000340994.4	c.7911+19T>C		intron_variant	Intron 49 of 60	5		ENSP00000341097.4

Frequencies

GnomAD3 genomes AF: 0.000427 AC: 65 AN: 152204 Hom.: 0 Cov.: 33

Gnomad AFR AF: 0.0000241

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.000851

Gnomad ASJ AF: 0.00144

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.000207

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00633

Gnomad NFE AF: 0.000603

Gnomad OTH AF: 0.000955

GnomAD2 exomes AF: 0.000497 AC: 125 AN: 251320 AF XY: 0.000515

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.000578

Gnomad ASJ exome AF: 0.00198

Gnomad EAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.000581

Gnomad OTH exome AF: 0.00130

GnomAD4 exome AF: 0.000331 AC: 474 AN: 1430962 Hom.: 2 Cov.: 26 AF XY: 0.000354 AC XY: 253 AN XY: 713826

Gnomad4 AFR exome AF: 0.00 AC: 0 AN: 32834

Gnomad4 AMR exome AF: 0.000537 AC: 24 AN: 44688

Gnomad4 ASJ exome AF: 0.00201 AC: 52 AN: 25894

Gnomad4 EAS exome AF: 0.00 AC: 0 AN: 39538

Gnomad4 SAS exome AF: 0.000304 AC: 26 AN: 85580

Gnomad4 FIN exome AF: 0.00 AC: 0 AN: 53406

Gnomad4 NFE exome AF: 0.000284 AC: 308 AN: 1084012

Gnomad4 Remaining exome AF: 0.000742 AC: 44 AN: 59298

GnomAD4 genome AF: 0.000427 AC: 65 AN: 152322 Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26 AN XY: 74488

Gnomad4 AFR AF: 0.0000241 AC: 0.0000240512 AN: 0.0000240512

Gnomad4 AMR AF: 0.000850 AC: 0.000849895 AN: 0.000849895

Gnomad4 ASJ AF: 0.00144 AC: 0.00144092 AN: 0.00144092

Gnomad4 EAS AF: 0.00 AC: 0 AN: 0

Gnomad4 SAS AF: 0.000207 AC: 0.000207039 AN: 0.000207039

Gnomad4 FIN AF: 0.00 AC: 0 AN: 0

Gnomad4 NFE AF: 0.000603 AC: 0.000602782 AN: 0.000602782

Gnomad4 OTH AF: 0.000945 AC: 0.00094518 AN: 0.00094518

Alfa AF: 0.000854 Hom.: 0

Bravo AF: 0.000355

Asia WGS AF: 0.000289 AC: 1 AN: 3478

ClinVar

Significance: Benign/Likely benign

Submissions summary: Uncertain:1 Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Polycystic kidney disease 4 Uncertain:1

Nov 02, 2017

Counsyl

Significance: Uncertain significance

Review Status: no assertion criteria provided

Collection Method: clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

not specified Benign:1

Jan 09, 2025

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Variant summary: PKHD1 c.7911+19T>C alters a conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00033 in 1576366 control chromosomes in the gnomAD database, including 2 homozygotes. This frequency is not higher than the maximum estimated for a pathogenic variant in PKHD1 causing Polycystic Kidney And Hepatic Disease (0.0071). The variant, c.7911+19T>C, has been reported in the literature in individuals affected with polycystic kidney disease (e.g. Sharp_2005, Nigro_2023), however, no supportive evidence for causality was provided. These reports do not provide unequivocal conclusions about association of the variant with Polycystic Kidney And Hepatic Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 15805161, 37372416). ClinVar contains an entry for this variant (Variation ID: 554778). Based on the evidence outlined above, the variant was classified as likely benign. -

Autosomal recessive polycystic kidney disease Benign:1

Dec 31, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.80
CADD	Benign	7.8
DANN	Benign	0.65
Mutation Taster		=97/3	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.12		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs201017366; hg19: chr6-51720672;